8:26 AM ET
8-K
Capital Raise
Moleculin Biotech Capital Raise
Moleculin Biotech raised $0.48 million in gross proceeds through the issuance of 888,400 shares under its at-the-market (ATM) offering program in September 2026. The issuance triggered an anti-dilution provision in the company's Series I Warrants, reducing their exercise price from $0.75 to $0.51 per share.
- Counterparty
- Roth Capital Partners, LLC